Additionally, Pim expression could correlate only with certain genetic mutations (ie. FLTD-ITD or FLTD-ITD), and therefore the percentage of AML patients in each data set harboring these mutations, which could explain varying levels of Pim kinases among studies. Here, PIM1 is linked to acute myeloid leukemia.